← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 30, 2016Last known activity
Jan 31, 2018
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 2 trials)
Phase 3 (4 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT03474276CollaboratorPhase 3Jan 31, 2018
- NCT02751476Lead sponsorN/AApr 30, 2016
Details
- Last known activity
- Jan 31, 2018